CPG 7909 in Patients With Cutaneous T-Cell Lymphoma

NCT00043420 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphoma, T-Cell, Cutaneous

Interventions

DRUG: PF-3512676
DRUG: PF-3512676
DRUG: PF-3512676
DRUG: PF-3512676
DRUG: PF-3512676
DRUG: PF-3512676
DRUG: PF-3512676
DRUG: PF-3512676

Sponsor

Pfizer